Headlines

NASDAQ:PTCT

Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Kristen Barton02 mins

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced its earnings results on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume…

Read More

Sizzling Stocks: PTC Therapeutics, Inc. (NASDAQ:PTCT), Frontier Communications Corporation (NASDAQ:FTR), The Michaels Companies, Inc. (NASDAQ:MIK), Southwest Gas Corporation (NYSE:SWX), China Unicom (NYSE:CHU)

Kevin Long03 mins

PTC Therapeutics (NASDAQ:PTCT) EVP Neil Gregory Almstead sold 26,096 shares of PTC Therapeutics stock on the open market in a transaction that occurred on Wednesday, January 21st. The shares were sold at an average price of $60.26, for a total value of $1,572,544.96. PTC Therapeutics, Inc. (NASDAQ:PTCT) belongs to Healthcare sector. Its weekly performance is…

Read More
Home